PeptideDB

EDTA-AM (EDTA acetoxymethyl ester; Ethylenediaminetetraacetic acid acetoxymethyl ester) 162303-59-5

EDTA-AM (EDTA acetoxymethyl ester; Ethylenediaminetetraacetic acid acetoxymethyl ester) 162303-59-5

CAS No.: 162303-59-5

EDTA-AM (ethylenediaminetetraacetic acid, acetoxymethyl ester) is a membrane-permeable (penetrable) form of the metal io
Data collection:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

EDTA-AM (ethylenediaminetetraacetic acid, acetoxymethyl ester) is a membrane-permeable (penetrable) form of the metal ion chelator EDTA. Living cells are loaded with EDTA-AM by incubating it with EDTA-AM. Once internalized cytosolic esterase decomposes AM, the active ligand EDTA is released, thereby separating the metal ions within the cell. EDTA-AM induces mitotic progression arrest and chromosome decondensation.

Physicochemical Properties


Molecular Formula C22H32N2O16
Molecular Weight 580.49
Exact Mass 580.175
CAS # 162303-59-5
PubChem CID 91872707
Appearance Colorless to light yellow liquid
Density 1.3±0.1 g/cm3
Boiling Point 607.0±55.0 °C at 760 mmHg
Flash Point 320.9±31.5 °C
Vapour Pressure 0.0±1.7 mmHg at 25°C
Index of Refraction 1.491
LogP 2.16
Hydrogen Bond Donor Count 0
Hydrogen Bond Acceptor Count 18
Rotatable Bond Count 27
Heavy Atom Count 40
Complexity 765
Defined Atom Stereocenter Count 0
SMILES

CC(=O)OCOC(=O)CN(CC(OCOC(C)=O)=O)CCN(CC(OCOC(C)=O)=O)CC(OCOC(C)=O)=O

InChi Key BYZOHUNEZPRPFB-UHFFFAOYSA-N
InChi Code

InChI=1S/C22H32N2O16/c1-15(25)33-11-37-19(29)7-23(8-20(30)38-12-34-16(2)26)5-6-24(9-21(31)39-13-35-17(3)27)10-22(32)40-14-36-18(4)28/h5-14H2,1-4H3
Chemical Name

acetyloxymethyl 2-[[2-(acetyloxymethoxy)-2-oxoethyl]-[2-[bis[2-(acetyloxymethoxy)-2-oxoethyl]amino]ethyl]amino]acetate
HS Tariff Code 2934.99.9001
Storage

Powder-20°C 3 years

4°C 2 years

In solvent -80°C 6 months

-20°C 1 month

Shipping Condition Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)

Biological Activity


ln Vitro Treatment of mitotic cells with EDTA-AM: 1. Gather mitotic cells and seed them onto a 12-well culture plate with coverslips coated in polylysine, 10% FBS added to the DMEM. 2. Once EDTA-AM has been dissolved in 100 mM DMSO, add it to the media that contains 0.02% Pluronic F-127 at a final concentration of 20 μM. Then, incubate the cells for an additional 100 minutes at 37°C. 3. Count the number of interphase and mitotic cells after incubation. After fixing, DAPI staining, and sealing with a portion of p-phenylenediamine (PPDI) solution (20 mM HEPES: pH 7.4, 1 mM MgCl 2, 100 mM KCl, 78% glycerol, 1 mg/mL PPDI), cells on coverslips were prepared.
References

[1]. Watkins CS, et.al. Effects on K+ currents in rat cerebellar granule neurones of a membrane-permeable analogue of the calcium chelator BAPTA. Br J Pharmacol. 1996 Aug;118(7):1772-8.

[2]. Maeshima K, et.al. A Transient Rise in Free Mg2+Ions Released from ATP-Mg Hydrolysis Contributes to Mitotic Chromosome Condensation. Curr Biol. 2018 Feb 5;28(3):444-451.e6.


Solubility Data


Solubility (In Vitro) May dissolve in DMSO (in most cases), if not, try other solvents such as H2O, Ethanol, or DMF with a minute amount of products to avoid loss of samples
Solubility (In Vivo) Note: Listed below are some common formulations that may be used to formulate products with low water solubility (e.g. < 1 mg/mL), you may test these formulations using a minute amount of products to avoid loss of samples.

Injection Formulations
(e.g. IP/IV/IM/SC)
Injection Formulation 1: DMSO : Tween 80: Saline = 10 : 5 : 85 (i.e. 100 μL DMSO stock solution 50 μL Tween 80 850 μL Saline)
*Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH ₂ O to obtain a clear solution.
Injection Formulation 2: DMSO : PEG300 :Tween 80 : Saline = 10 : 40 : 5 : 45 (i.e. 100 μL DMSO 400 μLPEG300 50 μL Tween 80 450 μL Saline)
Injection Formulation 3: DMSO : Corn oil = 10 : 90 (i.e. 100 μL DMSO 900 μL Corn oil)
Example: Take the Injection Formulation 3 (DMSO : Corn oil = 10 : 90) as an example, if 1 mL of 2.5 mg/mL working solution is to be prepared, you can take 100 μL 25 mg/mL DMSO stock solution and add to 900 μL corn oil, mix well to obtain a clear or suspension solution (2.5 mg/mL, ready for use in animals).
Injection Formulation 4: DMSO : 20% SBE-β-CD in saline = 10 : 90 [i.e. 100 μL DMSO 900 μL (20% SBE-β-CD in saline)]
*Preparation of 20% SBE-β-CD in Saline (4°C,1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution.
Injection Formulation 5: 2-Hydroxypropyl-β-cyclodextrin : Saline = 50 : 50 (i.e. 500 μL 2-Hydroxypropyl-β-cyclodextrin 500 μL Saline)
Injection Formulation 6: DMSO : PEG300 : castor oil : Saline = 5 : 10 : 20 : 65 (i.e. 50 μL DMSO 100 μLPEG300 200 μL castor oil 650 μL Saline)
Injection Formulation 7: Ethanol : Cremophor : Saline = 10: 10 : 80 (i.e. 100 μL Ethanol 100 μL Cremophor 800 μL Saline)
Injection Formulation 8: Dissolve in Cremophor/Ethanol (50 : 50), then diluted by Saline
Injection Formulation 9: EtOH : Corn oil = 10 : 90 (i.e. 100 μL EtOH 900 μL Corn oil)
Injection Formulation 10: EtOH : PEG300:Tween 80 : Saline = 10 : 40 : 5 : 45 (i.e. 100 μL EtOH 400 μLPEG300 50 μL Tween 80 450 μL Saline)

Oral Formulations Oral Formulation 1: Suspend in 0.5% CMC Na (carboxymethylcellulose sodium)
Oral Formulation 2: Suspend in 0.5% Carboxymethyl cellulose
Example: Take the Oral Formulation 1 (Suspend in 0.5% CMC Na) as an example, if 100 mL of 2.5 mg/mL working solution is to be prepared, you can first prepare 0.5% CMC Na solution by measuring 0.5 g CMC Na and dissolve it in 100 mL ddH2O to obtain a clear solution; then add 250 mg of the product to 100 mL 0.5% CMC Na solution, to make the suspension solution (2.5 mg/mL, ready for use in animals).
Oral Formulation 3: Dissolved in PEG400
Oral Formulation 4: Suspend in 0.2% Carboxymethyl cellulose
Oral Formulation 5: Dissolve in 0.25% Tween 80 and 0.5% Carboxymethyl cellulose
Oral Formulation 6: Mixing with food powders

Note: Please be aware that the above formulations are for reference only. InvivoChem strongly recommends customers to read literature methods/protocols carefully before determining which formulation you should use for in vivo studies, as different compounds have different solubility properties and have to be formulated differently.

 (Please use freshly prepared in vivo formulations for optimal results.)
Preparing Stock Solutions 1 mg 5 mg 10 mg
1 mM 1.7227 mL 8.6134 mL 17.2268 mL
5 mM 0.3445 mL 1.7227 mL 3.4454 mL
10 mM 0.1723 mL 0.8613 mL 1.7227 mL
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.